Work

Abstract C65: Overcoming docetaxel resistance through m-TOR inhibition: A phase I study of the combination of docetaxel and temsirolimus.

Year: 2011

Type: conference-abstract

Source: Molecular Cancer Therapeutics

DOI: 10.1158/1535-7163.targ-11-c65

Authors: Ignacio Duran, Clara Montagut, Emiliano Calvo, Alicia Navarrete, Antonia Garcia, Manuel Hidalgo, Jesus Rodriguez-Pascual, Antonio Cubillo, Coral Barbas, Juan F. Rodriguez-Moreno, Lorena Sanchez, Susana Galtes, Belen Valenzuela, Andrea Viqueira, Joaquin Bellmunt

Institutions: Hospital Del Mar, Universidad San Pablo CEU, Hospital Quirón Torrevieja, Pfizer (Spain)

Language: English

Topic: PI3K/AKT/mTOR signaling in cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1975041356

Cites:

Cited by:

Related to: 10